KAMI WIEDEMAN: Open Payments
NPI 1710974969 · MONROE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,543 in 90 payments from 17 companies in 2025. Trend: 2023 $1,909 · 2024 $1,537 · 2025 $1,543
Food & beverage: $1,543
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 20 | $257 |
| Abbott Laboratories | 2 | $246 |
| Merck Sharp & Dohme LLC | 10 | $232 |
| Amgen Inc. | 24 | $169 |
| Novartis Pharmaceuticals Corporation | 7 | $131 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $98 |
| Philips North America LLC | 4 | $72 |
| PFIZER INC. | 3 | $54 |
| E.R. Squibb & Sons, L.L.C. | 3 | $50 |
| SCPHARMACEUTICALS INC. | 3 | $45 |
Products named: JARDIANCE, AVEIR, VERQUVO, REPATHA, LEQVIO, Kerendia, ELIQUIS, LM Undivided.
Industry payments across LA — which companies pay providers there.
